Literature DB >> 942859

SS-interchanged and oxidized isomers of bovine serum albumin separated by isoelectric focusing.

K Wallevik.   

Abstract

Column isoelectric focusing separates commercial bovine serum albumin in 5 fractions with isoionic points in the vicinity of that of mercaptalbumin (pI 5.24). About 20% of the bovine albumin have isoionic points higher than mercaptalbumin and are split into two fractions, both recognized as SS-interchanges isomers: (1) pI 5.39 is the "aged" albumin described by Nikkel and Foster (1971, Biochemistry 10, 4479); (2) pI 5.45 represents a further degree of SS-interchange, catalyzed by small amounts of cysteine in the solution ('cysteine-aged' albumin). In 6 M urea the "cysteine-aged" albumin is electrofocused to the same pH value as mercaptalbumin. In 6 M urea 40% of commercial albumin focuses in 3 fractions with isoionic points lower than mercaptalbumin. This percentage will increase during incubation at oxidizing conditions ("oxidized" albumin). Electrofocused in water the oxidized fractions have isoionic points at pI 5.28, 5.18 and 5.12, respectively. The shifts in isoionic point of the "oxidized" albumins are caused by irreversible changes in the primary structure. Although the free SH group of albumin is oxidized during the oxidation reaction, the observed changes in isoionic points are caused by modifications of some other amino acid residues. Both "cysteine-ageing" and "oxidation" are inhibited by alkylation of the SH group. "Cysteine-ageing" is furthermore inhibited when the bovine albumin is "oxidized".

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942859     DOI: 10.1016/0005-2795(76)90343-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Solution structure of the C-terminal domain of Ole e 9, a major allergen of olive pollen.

Authors:  Miguel A Treviño; Oscar Palomares; Inés Castrillo; Mayte Villalba; Rosalía Rodríguez; Manuel Rico; Jorge Santoro; Marta Bruix
Journal:  Protein Sci       Date:  2007-12-20       Impact factor: 6.725

2.  Covalent binding between bucillamine derivatives and human serum albumin.

Authors:  R Narazaki; M Hamada; K Harada; M Otagiri
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

3.  Structural properties of homogeneous protein disulphide-isomerase from bovine liver purified by a rapid high-yielding procedure.

Authors:  N Lambert; R B Freedman
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

4.  Spontaneous in vivo isomerization of bovine serum albumin as a determinant of its normal catabolism.

Authors:  K Wallevik
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

5.  In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time.

Authors:  H Watanabe; K Yamasaki; U Kragh-Hansen; S Tanase; K Harada; A Suenaga; M Otagiri
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

6.  HPLC separation of human serum albumin isoforms based on their isoelectric points.

Authors:  Lucía Turell; Horacio Botti; Lucía Bonilla; María José Torres; Francisco Schopfer; Bruce A Freeman; Larissa Armas; Alejandro Ricciardi; Beatriz Alvarez; Rafael Radi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-20       Impact factor: 3.205

7.  Control of 5-aminolaevulinate synthetase activity in Rhodopseudomonas spheroides. Purification and properties of the high-activity form of the enzyme.

Authors:  R C Davies; A Neuberger
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

8.  Dependence of reaction rate of 5,5'-dithiobis-(2-nitrobenzoic acid) to free sulfhydryl groups of bovine serum albumin and ovalbumin on the protein conformations.

Authors:  K Takeda; A Shigemura; S Hamada; W Gu; D Fang; K Sasa; K Hachiya
Journal:  J Protein Chem       Date:  1992-04

9.  Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases.

Authors:  R Narazaki; M Otagiri
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

10.  Albumin antioxidant response to stress in diabetic nephropathy progression.

Authors:  Rafael Medina-Navarro; Itzia Corona-Candelas; Saúl Barajas-González; Margarita Díaz-Flores; Genoveva Durán-Reyes
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.